Antioxidant and Vasodilator Composition for Inner Ear Blood Flow

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for age-related hearing loss (ARHL) are ineffective, as existing dietary supplements and chemical treatments fail to address the underlying mechanisms of reduced blood flow and antioxidant system efficiency in the inner ear, leading to hearing loss and tinnitus.

Innovation Solution

A composition comprising biologically effective amounts of vitamin A, vitamin E, vitamin C, a vasodilator such as magnesium, and optionally withanolide or resveratrol, which increases inner ear blood flow and supplements antioxidant properties to counteract free radical formation and vasoconstriction, thereby treating and preventing ARHL.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing dietary supplements and chemical treatments are used, then treatment attempts are made, but they fail to address the underlying mechanisms of reduced blood flow and antioxidant system efficiency

Engineering Contradiction:
Improveeffectiveness of treatmentVSAvoidmechanism complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The treatment is divided into four distinct functional components: (1) antioxidant vitamins (A, C, E) to address oxidative stress, (2) vasodilator (magnesium) to address blood flow reduction, (3) withanolide to address inflammation, and (4) resveratrol to address cellular aging. Each component targets a specific underlying mechanism of ARHL, making the treatment comprehensive and reliable.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses a composite formulation combining multiple substances with different mechanisms of action. This composite approach addresses the multifactorial nature of ARHL by integrating antioxidants, vasodilators, anti-inflammatories, and anti-aging agents into a single treatment protocol, thereby improving treatment reliability.

Inventive Principle:
Principle #40Composite materials

2Adaptability or versatility

If noise exposure is increased, then urban environment adaptation is improved, but hearing loss and tinnitus are exacerbated

Engineering Contradiction:
Improveurban environment adaptationVSAvoidhearing loss and tinnitus
Core Design Contradiction:
Adaptability or versatilityVSObject-affected harmful factors

Solution Approach 1:

The treatment provides preliminary protection against noise-induced damage by establishing adequate antioxidant levels and improved blood flow before noise exposure occurs. The antioxidant vitamins prevent free radical formation from noise stress, while the vasodilator ensures adequate blood supply to protect hair cells from noise-induced injury, thereby preventing hearing loss and tinnitus.

Inventive Principle:
Principle #9Preliminary anti-action

3Duration of action of stationary object

If age increases, then population growth is natural, but blood flow to inner ear and antioxidant efficiency are reduced

Engineering Contradiction:
Improvelife spanVSAvoidblood flow and antioxidant efficiency
Core Design Contradiction:
Duration of action of stationary objectVSReliability

Solution Approach 1:

The treatment performs preliminary actions to counteract age-related decline by pre-establishing adequate antioxidant levels and improved blood flow dynamics. The antioxidant vitamins prevent oxidative damage that accumulates with age, while the vasodilator maintains blood flow to the inner ear, thereby preserving hearing function throughout the lifespan.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition effectively reduces stress-induced threshold shifts and tinnitus by producing an additive effect greater than or equal to the sum of individual components, preserving hearing and preventing cell death in the inner ear.

Implementation Method 1

supplements antioxidant properties to counteract free radical formation

Methodology Applied
Scientific EffectAntioxidant action: Oxidation

Implementation Method 2

a vasodilator comprising magnesium, and, optionally, a withanolide, and/or resveratrol, which increases inner ear blood flow

Methodology Applied
Scientific EffectVasodilation:

Data Source

PatentUS9919008B2Method for treating age-related hearing loss (ARHL)
Publication Date: 2018.03.20 THE RGT UNIV OF MICHIGAN
  • US9919008B2 patent drawing
  • US9919008B2 patent drawing
  • US9919008B2 patent drawing

AI summary

A method for treating age-related hearing loss (ARHL) includes the step administering a composition to the mammal, wherein the composition consists essentially of a biologically effective amount of vitamin A, vitamin E, vitamin C, a vasodilator comprising magnesium, and, optionally, a withanolide, and/or resveratrol.